Takeda’s Vaccine Business Aims High, Led By Former Gates Foundation Vaccine Director
This article was originally published in PharmAsia News
Executive Summary
Established in January 2012 on the foundation of Takeda’s long-standing domestic pediatric vaccine business, the new initiative will be global in scale, building on the territorial gains from the Nycomed acquisition, and led by a seasoned player.